Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Anemia, Refractory, with Excess of Blasts 60Leukemia, Myeloid, Acute 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Myelodysplastic Syndromes 52Leukemia 47Leukemia, Myelomonocytic, Chronic 42Leukemia, Lymphocytic, Chronic, B-Cell 38Multiple Myeloma 36Lymphoma, Non-Hodgkin 36Leukemia, Myeloid, Chronic-Phase 35Myeloproliferative Disorders 34Hodgkin Disease 32Lymphoma 31Congenital Abnormalities 31Leukemia, Myeloid, Accelerated Phase 29Lymphoma, Follicular 28Burkitt Lymphoma 28Primary Myelofibrosis 27Lymphoma, Mantle-Cell 25Anemia, Refractory 25Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Large B-Cell, Diffuse 24Lymphoma, B-Cell, Marginal Zone 24Blast Crisis 22Anemia, Aplastic 19Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Polycythemia Vera 17Dendritic Cell Sarcoma, Interdigitating 17Recurrence 16

Interventions

Thiotepa 3Melphalan 3Cyclophosphamide 3fludarabine phosphate 2fludarabine 2Busulfan 2Alemtuzumab 2Whole-Body Irradiation 1Tacrolimus 1Muromonab-CD3 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Immunotherapy 1Drug Therapy 1Antilymphocyte Serum 1Antibodies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Histiocytosis × fludarabine phosphate × Classical hematology × Clear all
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡